Study Summary
This trial will compare dural venous sinus stenting to the current standard treatment (CSF shunting) for pseudotumor cerebri (IIH) patients with moderate vision loss and stenosis of the dural venous sinuses.
- Pseudotumor Cerebri
- Idiopathic Intracranial Hypertension
Treatment Effectiveness
Effectiveness Progress
Study Objectives
1 Primary · 6 Secondary · Reporting Duration: Study entry, six months and One year
Trial Safety
Trial Design
2 Treatment Groups
Cerebrospinal Fluid Shunting
1 of 2
Dural Venous Sinus Stenting
1 of 2
Active Control
Experimental Treatment
80 Total Participants · 2 Treatment Groups
Primary Treatment: Dural Venous Sinus Stenting · No Placebo Group · N/A
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18+ · All Participants · 8 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Who else is applying?
What state do they live in?
| California | 100.0% |
How old are they?
| 18 - 65 | 100.0% |
What portion of applicants met pre-screening criteria?
| Did not meet criteria | 100.0% |
Frequently Asked Questions
Are volunteers able to participate in this experiment right now?
"Indeed, the records on clinicaltrials.gov support that this medical trial is actively accepting participants. It was initially posted in June 3rd 2020 and last revised on September 20th 2021; it needs 80 individuals to be recruited from 2 different medical centres." - Anonymous Online Contributor
What is the capacity for participants in this investigation?
"Indeed, the information found on clinicaltrials.gov reveals that recruitment for this study is ongoing. It was first posted on June 3rd 2020 and has undergone its latest update as of September 20th 2021. The trial requires 80 participants to be recruited from 2 medical sites." - Anonymous Online Contributor